Loading clinical trials...
Loading clinical trials...
The goal of this laboratory study is to establish whether and which microdoses of psilocybin are safe to administer at home to healthy participants. Eligible participants will be given ascending dose...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Johns Hopkins University
Collaborators
NCT05866471 · Healthy, Psychedelic Experiences, and more
NCT05698511 · Psychedelic Experiences, Neuroimaging, and more
NCT07360301 · Well-Being, Psychological, Psychedelic Experiences
NCT05592379 · Healthy, Psychedelic Experiences, and more
NCT06529939 · Disorders of Consciousness, Psychedelic Experiences
5510 Nathan Shock Drive
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions